IncFact
Company Profiles: Revenue, Growth, Competition

MYRIAD GENETIC LABORATORIES Revenue, Growth & Competitor Profile

DBA MYRIAD GENETICS, INC.
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Myriad Genetic Laboratories

Access the complete profile.

Myriad Genetic Laboratories Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry6215 Medical & Diagnostic Laboratories
Address320 Wakara Way
Salt Lake City, UT 84108

myriad.com


Myriad Genetic Laboratories's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medical & Diagnostic Laboratories industry.


Myriad Genetic Laboratories's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Myriad Genetic Laboratories is a publicly traded company on using the ticker symbol MYGN. Detailed information on company financials and operating reports can be found here: : MYGN



Myriad Genetic Laboratories Annual Revenue and Growth Rate

Myriad Genetic Laboratories Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Myriad Genetic Laboratories's revenues are gauged from an analysis of company filings.



Investor Activity

Myriad Genetic Laboratories has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
February 12, 2019 1 100%$0 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Myriad Genetic Laboratories is developing and marketing. Myriad Genetic Laboratories's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PRECISE TREATMENT REGISTRY
Providing multiple user access to proprietary collections of information relating to clinical data by means of global computer information networks
07/12/2023
PRECISE ONCOLOGY SOLUTIONS
Medical testing services for the purpose of testing for biomarkers; genetic and genomic testing related to biomarkers for medical purposes; diagnostic testing in the field of gene sequencing and gene expression profiling for individual cancers, for medical diagnostic and treatment purposes
07/07/2023
PRECISE TUMOR
Medical testing services related to oncology; genetic and genomic testing related to oncology
07/07/2023

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Myriad Genetic Laboratories grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Myriad Genetic Laboratories is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medical & Diagnostic Laboratories

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Myriad Genetic Laboratories's Largest Competitors

A competitive analysis shows these companies are in the same general field as Myriad Genetic Laboratories, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LABORATORY CORPORATIONEnglewood, CO100 
TRYKO PARTNERSBrick, NJ24 
SONIC HEALTHCARE USAAustin, TX15 
KPC GLOBAL MANAGEMENTHemet, CA14 
EXACT SCIENCES THRIVEMadison, WI12 
MODERNATXCambridge, MA10 
NOVAVAXGaithersburg, MD9 
JAMES R. GLIDEWELL DENTAL CERAMICSNewport Beach, CA9 
BIO-RAD LABORATORIESHercules, CA8 




Nearby Competitors

These companies are similar in business line and location to Myriad Genetic Laboratories. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
MYRIAD GENETIC LABORATORIESSalt Lake City, UT100 
LINEAGENSalt Lake City, UT1 
CIBUS BIOTECHNOLOGIESSalt Lake City, UT1 
PYREXAR MEDICALWest Valley City, UT1 
ALUCENT BIOMEDICALSalt Lake City, UT1 
JUNEAU BIOSCIENCESSalt Lake City, UT0 




Future Competition: Myriad Genetic Laboratories's Fastest Growing Competitors

These companies are in the same general field as Myriad Genetic Laboratories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Myriad Genetic Laboratories Competitors